Commonwealth Biotechnologies Inc sold intellectual property rights to an Australian-based company, Biosignal, and got a $2.6 million payday in return.
Biosignal purchased the rights to a biofilm disruption technology buy buying stock in CBI.
Think of biofilm as ice on your windshield. It forms on your windshield and makes the vehicle inoperable until it’s removed. Biofilm works like that only it inhibits the growth of organisms that can be later used in medical technology such as pharmaceuticals.
From an article in Tech Journal South.
The biofilm technology is based around a family of natural products which disrupt bacterial colonization and thereby inhibit growth. Such biofilm disrupters are expected to be commercialized to support a variety of medical and industrial applications.
See more coverage of CBI here.
David Larter covers health care for BizSense. Please send news tips to david@richmonbizsense.com
Your article on CBI and Biosignal is all upside down. You need to re-read the announcement. Regards